Frederick L. Baehner

机构：Abbott (United States), Exact Sciences (United States), Wilderness Inquiry · ORCID：0000-0001-6883-1212

发表论文 262 篇 · 总被引 28695 次 · h-index 49

代表论文

• Gene Expression and Benefit of Chemotherapy in Women With Node-Negative, Estrogen Receptor–Positive Breast Cancer (2023 · Journal of Clinical Oncology · 被引 160)
• Ultrasensitive Circulating Tumor DNA Pilot Study Distinguishes Complete Response and Partial Response With Immunotherapy in Patients With Metastatic Renal Cell Carcinoma (2023 · JCO Precision Oncology · 被引 23)
• Clinical and Genomic Risk for Late Breast Cancer Recurrence and Survival (2024 · NEJM Evidence · 被引 20)
• Development and Validation of the RSClinN+ Tool to Predict Prognosis and Chemotherapy Benefit for Hormone Receptor–Positive, Node-Positive Breast Cancer (2024 · Journal of Clinical Oncology · 被引 17)
• Circulating Tumor DNA as a Marker of Recurrence Risk in Stage III Colorectal Cancer: The α‐CORRECT Study (2025 · Journal of Surgical Oncology · 被引 13)
• HER2-low status as a distinct breast cancer subtype: myth or truth? Analysis of the WSG trials WSG-ADAPT-HR+/HER2-, WSG-PlanB, and WSG-ADAPT-TN (2025 · Breast Cancer Research · 被引 9)